A multidisciplinary approach to establishing clozapine in a patient with schizophrenia and comorbid ASD: a case report.

This study looked at a person with autism and schizophrenia who needed a strong medication called clozapine for their mental health symptoms. People with autism might have more side effects from this medication, so doctors needed to work together as a team and be extra careful when starting treatment. The study shows that having both autism and schizophrenia can make treatment more complicated.

This case report describes the challenges and considerations involved in prescribing clozapine to a patient with both schizophrenia and autism spectrum disorder (ASD). The patient experienced psychosis that was unresponsive to multiple antipsychotic medications, necessitating clozapine treatment. However, individuals with ASD may face increased risk of certain clozapine adverse effects, requiring extra precautionary measures. The authors emphasize that successful clozapine initiation in this population requires a coordinated multidisciplinary approach to manage the complex interplay between ASD characteristics and medication effects.

The study highlights the substantial symptom overlap between psychosis and ASD, noting that co-occurrence of these conditions is common and may influence antipsychotic treatment response.

Clinicians should exercise heightened caution when prescribing clozapine to patients with ASD and psychosis. A coordinated multidisciplinary team approach is essential for safe implementation. Enhanced monitoring protocols may be necessary to manage increased adverse effect risk in this vulnerable population.

Single case report limits generalizability. No detailed adverse event data provided. Lacks specific information about the multidisciplinary approach implemented. No quantitative outcome measures reported. Sample size of one prevents broader clinical application.

There is substantial symptom overlap in psychosis and autism spectrum disorder (ASD) and co-morbidity is common. In addition, antipsychotic response may be moderated by the co-occurrence. Individuals with ASD may be at greater risk of some clozapine adverse effects and occasionally, its use may be contra-indicated. We present the case of a patient with ASD with psychosis unresponsive to multiple antipsychotics, but extra precaution was required with clozapine.

A multidisciplinary approach is required to establish clozapine in a patient with schizophrenia and ASD.